In order to treat an underserved population of patients with a rare condition whose muscles gradually become weaker until they can no longer walk, a team of researchers across Japan have completed a ...
Please provide your email address to receive an email when new articles are posted on . 47.5% of patients treated with glucocorticoids reported myopathy. Cumulative dosage, age, sex and weight were ...
In order to treat an underserved population of patients with a rare condition whose muscles gradually become weaker until they can no longer walk, a team of researchers across Japan have completed a ...
The Defibrillators in Non-ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) trial was conducted to evaluate the prophylactic implantation of an ICD to prevent sudden death in patients with ...
Treating children with cardiomyopathy should be personalized based on the root cause, symptoms and progression of the condition in each child , according to a new American Heart Association scientific ...
Cytokinetics, Incorporated announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for aficamten, a cardiac myosin inhibitor aimed at treating ...
Mean change in UEC total score from the start of the Phase2/3 study (Week 0) to the final evaluation time point (Week 120) of the extension study. Closed circle and solid line, SA-ER/SA-ER group; open ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results